# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
https://www.marijuanamoment.net/gop-congressional-committee-approves-bill-to-block-marijuana-rescheduling-while-rejecting-state...
- Preliminary Analysis confirms the presence of TGR-63 in brain tissue and shows no adverse effects. -IGC Pharma, Inc. (NYSE:IG...
https://www.marijuanamoment.net/california-legislature-approves-bill-to-break-psychedelics-research-logjam-sending-it-to-governor/
IGC Pharma (AMEX:IGC) reported quarterly losses of $(0.04) per share. The company reported quarterly sales of $295.000 thousan...
Ascendiant Capital analyst Edward Woo reiterates IGC Pharma (AMEX:IGC) with a Buy and maintains $3.25 price target.
-- Study Deepens Understanding of Treatments for Alzheimer's Patients, Enabling More Effective Treatments --